Skip to main content

stock

TLSI · TriSalus Life Sciences, Inc.

What TriSalus Life Sciences, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live TLSI price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on TLSI.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
61,574,600 as of 2026-08-04 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
85.8%
Operating
-67.7%
Net
-62.6%

Returns

ROE
-430.7%
ROA
-45.2%

Health

Current ratio
5.3x
Debt/equity
5.0x

Deep value

NCAV
$3.85M
NCAV per share
$0.06
Price/NCAV
Locked
NNWC
-$2.66M
NNWC per share
-$0.04
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$11.41M$9.90M-$9.81M-$9.19M
10-Q filed 2026-08-06
2026-03-31$8.90M$7.67M-$8.41M$1.54M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$13.21M$11.44M-$3.27M-$9.75M
10-K filed 2026-03-05
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$11.57M$9.66M-$9.01M-$10.81M
10-Q filed 2025-11-13
2025-06-30$11.21M$9.41M-$7.33M-$8.29M
10-Q filed 2026-08-06
2025-03-31$9.17M$7.67M-$7.33M-$10.38M
10-Q filed 2026-08-06
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$8.26M$7.04M-$7.58M-$10.11M
10-K filed 2026-03-05
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$7.35M$6.34M-$8.74M-$2.40M
10-Q filed 2025-11-13
Assets
$62.45M
Equity
$6.55M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$45.15M-$26.95M-$39.23M-$18.93M
2024-12-31$29.43M-$36.16M-$30.05M-$41.19M
2023-12-31$18.51M-$54.48M-$59.36M-$51.17M
2022-12-31$12.40M-$36.44M-$47.19M-$32.97M
2021-12-31—-$3.04M$4.77M—

Company filings

since Thu Nov 13 · 3 offering filings in 12 months

events

  • Other event

    Other event
    Sep 228-K
  • Results

    Results
    Aug 68-K
  • Shareholder vote results

    Shareholder vote results
    May 148-K
  • Results

    Results
    May 128-K
  • Executive or director change

    Executive or director change
    Apr 298-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Apr 78-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named TLSI, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about TLSI.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about TLSI.

nakagai

Signals on TLSI come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the TLSI board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

TriSalus Life Sciences, Inc. (TLSI): SEC filings, financials and insider trades · Nakagai